name

Carlos Blanco

HQ Location: Spain

RANK #430

Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders.
His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders
Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute. He is a graduate of Universidad Autónoma de Madrid (Spain) and completed his psychiatry residency at Columbia University, where he also completed a research fellowship. Dr. Blanco has authored over 200 peer-reviewed publications.

Numbers of Unicorns

1

435

Rank (Xs)

#430

Investments

46

Exits

27

Numbers of Unicorns

1

435

Rank (Xs)

#430

Investments

46

Exits

27

All Unicorns

Logo

Company name

ENTRY ROUND

VALUATION at entry ($M)

VALUATION 

Glovo

Glovo

Seed

$6M

417

$2500M

All $100M+

Company name

ENTRY ROUND

VALUATION at entry ($M)

VALUATION 

2473

Housfy

$6.66M

6

$39.73M

1316

Deporvillage

$20.13M

10

$193M

2415

Holded

Series B

$54.07M

3

$146.05M

The information is provided for informational purposes.  The company does not bear any responsibility for the published data.